Skip to main content
Pharmacognosy Reviews logoLink to Pharmacognosy Reviews
. 2013 Jul-Dec;7(14):179–187. doi: 10.4103/0973-7847.120520

A review on phytochemistry and ethnopharmacological aspects of genus Calendula

Disha Arora 1, Anita Rani 1, Anupam Sharma 1
PMCID: PMC3841996  PMID: 24347926

Abstract

This review includes 84 references on the genus Calendula (Asteraceae) and comprises ethnopharmacology, morphology and microscopy, phytoconstituents, pharmacological reports, clinical studies and toxicology of the prominent species of Calendula. Triterpene alcohols, triterpene saponins, flavonoids, carotenoids and polysaccharides constitute major classes of phytoconstituents of the genus. A few species of this genus have medicinal value, among these Calendula officinalis Linn., has been traditionally used in the treatment of various skin tumors, dermatological lesions, ulcers, swellings and nervous disorders as well as almost 200 cosmetic formulations, i.e., creams, lotions, shampoos. Despite a long tradition of use of some species, the genus has not been explored properly. In the concluding part, the future scope of Calendula species has been emphasized with a view to establish their multifarious biological activities and mode of action.

Keywords: Calendula, carotenoids, flavonoids, triterpene alcohols

INTRODUCTION

This review emphasizes the traditional uses and clinical potential of Calendula species. The review is intended to attract the attention of natural product researchers throughout the world to focus on the unexplored potential of the Calendula species. This genus needs to be investigated systematically so that potential species can be exploited as therapeutic agents.

The review has been compiled using references from major databases such as Chemical Abstracts, Medicinal and Aromatic Plant Abstracts, PubMed, King's American Dispensatory, Henriette's Herbal Homepage, Duke's Phytochemical and Ethnobotany. The available information on Calendula has been divided into six sections, i.e., ethnopharmacology, morphology and microscopy, phytoconstituents, pharmacological reports, clinical studies and toxicology.

THE GENUS CALENDULA

The genus Calendula (Asteraceae) includes approximately 25 herbaceous annual or perennial species, most common being Calendula officinalis Linn., Calendula arvensis Linn., Calendula suffruticosa Vahl., Calendula stellata Cav., Calendula alata Rech., Calendula tripterocarpa Rupr.[1] The genus is native to the Mediterranean countries.[2]

Ethnopharmacology

Traditional uses

C. alata Rech.f., aerial parts are used for the treatment of kidney stones and gall stones.[3]

C. arvensis Linn. (Field marigold) has been used as disinfectant, antispasmodic and diuretic.[4] In Italian folk medicine, the plant is used as anti-inflammatory, anticancer and antipyretic agent.[5] In Spain, the leaves are considered sudorific. Traditionally, it is used as an emmenagogue, diaphoretic and sedative.[6] It is known to have wound healing properties and crushed leaves are topically applied on wounds.[7] The decoction of the flower heads has been used for treating burns.[8]

C. officinalis Linn. (Pot marigold) has been traditionally used in the treatment of inflammations of internal organs, gastrointestinal ulcers and dysmenorrhea and as a diuretic and diaphoretic in convulsions. It is also used for inflammations of the oral and pharyngeal mucosa, wounds and burns.[9] Calendula is a cleansing and detoxifying herb and the infusion treat chronic infections.[10] The dried flower heads have been used for their antipyretic, anti-tumor and cicatrizing effects.[11] Topical application of infusion of flowers is used as antifungal and antiseptic in wounds, marks, freckles, sprain and conjunctivitis.[12] Calendula tea is used as eyewashes, gargles, diaper rashes and other inflammatory conditions of the skin and mucous membranes.[13] Mother tincture of C. officinalis is used in homoeopathy for the treatment of mental tension and insomnia.[14]

Medicinal properties of C. officinalis have been mentioned in Ayurvedic and Unani system of medicine indicating that leaves and flowers are antipyretic, anti-inflammatory, antiepileptic and antimicrobial.[15] In traditional and homoeopathic medicine, C. officinalis has been used for poor eyesight, menstrual irregularities, varicose veins, hemorrhoids and duodenal ulcers.[16] In the middle ages, Calendula flowers were used for liver obstructions, snake bites and to strengthen the heart. It was used in the 18th century as a remedy for headache, jaundice and red eyes. The plant was employed in the civil war to treat wounds and as a remedy for measles, smallpox and jaundice.[17]

Decoction and infusion of Calendula persica C.A. Mey aerial parts are employed for the treatment of kidney stones.[3]

Alternative and complementary medicinal uses

Among the various species of the genus Calendula, C. officinalis is the only one, which is extensively used clinically throughout the world. The plant is listed in German Commission E, European Scientific Co-operative on Phytotherapy, British Herbal Pharmacopoeia, World Health Organization monographs for wound healing and anti-inflammatory actions.[18] C. officinalis preparations are used in various complementary and alternative medicine systems mainly for burns, cuts, rashes, dermatitis and varicosis.[19] It is also included as part of treatment for dry skin, bee stings and foot ulcers.[20] The essential oil of the plant is used for soothing central nervous system and as a wound healer.[21]

C. officinalis preparations currently in use include carophyllenic ointment (containing carotenoids extracted from the flowers) and pot marigold tincture. It is one of the constituents of proprietary homoeopathic medicine Traumeel®, used for treating the symptoms associated with acute musculoskeletal injuries including pain and swelling.[22] Otikon otic solution and naturopathic herbal extract ear drops solution, ear drop formulations of naturopathic origin containing Calendula flowers, have been reported to be effective for the management of otalgia associated with acute otitis media in children.[23,24]

Morphology and microscopy

C. arvensis Linn. is an annual herb, not generally exceeding 15 cm in height. Leaves lance-shaped; stem slender, hairy; inflorescence single flower head up to 4 cm wide with bright yellow to yellow-orange ray florets around a center of yellow disc florets.[25,26]

C. officinalis Linn. [Figure 1] is an annual or biennial plant attaining height of 30-60 cm. Leaves lower spatulate, 10-20 cm long and 1-4 cm wide; higher oblong and mucronate, 4-7 cm long; stem angular, hairy and solid; flower heads bright yellow to orange; marginal flowers in cultivated plants multi-seriate, corolla oblong spatulate, 15-25 mm long and 3 mm wide; corolla of disc flowers rounded, at the top tridentate, 1.5-2.5 cm long and 4-7 mm in diameter with 5 mm long tubular florets.[27,28]

Figure 1.

Figure 1

Calendula officinalis L

The powdered C. officinalis is yellowish brown with a characteristic, aromatic odor and a slightly bitter taste; comprises fragments of the corolla, anomocytic stomata in the apical region of outer epidermis, covering and glandular trichomes, elongated sclerenchymatous cells, pollen grains, fragments of the walls of the ovaries containing brown pigment, fragments of stigma, fragments of the fibrous layer of the others.[29,30]

C. stellata Cav., is a small, attractive annual growing to a height of 30 cm or more. Leaves oval or oblong, somewhat pointed, wavy-toothed;[31] stems scabrous; achenes outer five with membranous toothed margins, the five inner ones “boat-shaped” and smooth on the back, the rest angular and muricated on the back.[32]

C. suffruticosa Vahl., is a perennial plant reaching a height between 20 cm and 40 cm. Leaves lance-shaped, slightly toothed, covered with short sticky hairs; stem young one first erected, later begin to hang and spread to the soil; flowers bright yellow, each measuring about 2.5 cm in diameter.[31,33]

Phytoconstituents

Four species of Calendula have been investigated phytochemically. Table 1 summarizes the phytoconstituents of different species of Calendula. Figure 2 represents chemical structures of some phytoconstituents reported from the genus Calendula.

Table 1.

Phytoconstituents of different species of Calendula

graphic file with name PRev-7-179-g002.jpg

Figure 2.

Figure 2

Chemical structures of some phytoconstituents reported from the genus Calendula

Pharmacological reports

The available literature reveals that amongst 12-20 species of Calendula, only three species, i.e., C. officinalis, C. arvensis and C. suffruticosa have been evaluated for their pharmacological activities.

Tincture of C. arvensis was active against Staphylococcus aureus at concentrations of 10 mg/ml or 25 mg/ml.[56] Sesquiterpene glycosides from C. arvensis were able to inhibit vesicular stomatitis virus infection.[57] A saponin containing fraction from the aerial parts of C. arvensis had hemolytic activity in vitro and anti-inflammatory activity against carrageenan induced paw edema in rats.[58] Saponins showed antimutagenic activity against benzo (a) pyrene 1 μg and mutagenic urine concentrate from a smoker (SU) 5 μL with a dose-response relationship.[59]

Preparations of C. officinalis are mainly applied in the form of infusions, tinctures and ointments as a wound healing remedy for inflammations of the skin, mucous membranes, for poorly healing wounds, bruises, boils and rashes, e.g., pharyngitis and leg ulcers.[27] In the mixed lymphocyte reaction, 70% ethanol extract showed stimulatory effects at 0.1-10 μg/ml, followed by inhibition at higher concentrations.[60] Phagocytosis of human granulocytes was stimulated by polysaccharides isolated from aqueous extract of Calendula flowers.[61] Extracts of Calendula flowers of differing polarities exhibited anti-oxidative effects on liposomal lipid peroxidation induced by Fe2 + and ascorbic acid.[62,63] Isorhamnetin 3-glycosides from Calendula flowers inhibited lipoxygenase from rat lung cytosol at a concentration of 1.5 × 10-5 M.[64] In a test system based on porcine buccal membranes, strong concentration dependent adhesive processes were observed with a low viscosity polysaccharide enriched extract (98% carbohydrates) of Calendula flowers. These findings suggested that the polysaccharides may contribute to therapeutic effects in the treatment of irritated mucosa.[65] A triterpene enriched fraction given orally to mice inoculated with Ehrlich mouse carcinoma prevented the development of ascites and increased survival time compared to control.[66] Triterpenes such as faradiol and taraxasterol inhibit experimental tumor promotion and are therefore considered as inhibitors of tumor growth.[67] A saponin rich fraction administered orally at 50 mg/kg body weight to hyperlipemic rats reduced the serum lipid level.[68,69] The aqueous alcohol extract of C. officinalis showed central nervous system inhibitory effect with marked overall sedative activity as well as hypotensive effect.[70] The alcohol extract of flowers of C. officinalis possesses anti-HIV properties.[71] A cream containing calendula extract has been reported to be effective in dextran and burn edemas as well as in acute lymphedema in rats. Activity against lymphedema was primarily attributed to enhancement of macrophage proteolytic activity.[72] The essential oil of the flowers inhibited the growth in vitro of Bacillus subtilis, Escherichia coli, S. aureus, Pseudomonas aeruginosa and Candida albicans.[73] Acetone, ethanol or water extracts inhibited the growth in vitro of the fungus Neurospora crass.[74] A flavonoid fraction isolated from the flowers inhibited the in vitro growth of S. aureus, Sarcina lutea, E. coli, Klebsiella pneumonia and Candida monosa.[75] The 50% ethanol extract of the plant showed spermicidal activity in rats at 2% concentration.[76]

C. suffruticosa inhibited pathogenic micro-organisms, especially Pseudomonas syringae, Pseudomonas fluorescens, Xanthomonas campestris, Agrobacterium tumefaciens.[77]

Clinical studies

In a randomized, open controlled study, the effects of three ointments were compared after topical treatment of patients with 2nd or 3rd degree burns for 17 days: Calendula flower ointment (prepared by digestion in vaseline) (n = 53) or vaseline only (n = 50) or a proteolytic ointment (n = 53). The success rates were considered to be 37/53 for Calendula flower ointment, 27/50 for vaseline and 35/53 for the proteolytic ointment.[78] In an open uncontrolled pilot study, 30 patients with burns or scalds were treated 3 times/day for up to 14 days with a hydrogel containing 10% of a hydro-ethanol extract. The symptoms reddening, swelling, blistering, pain, soreness and heat sensitivity were scored before, during and at the end of treatment. Total score and individual scores for each symptom improved.[79] In women with surgical wounds, local application of a mixture containing 70% oily extract of Hypericum perforatum and 30% oily extract of C. arvensis improved the rate of healing, compared with controls.[53] Phase III randomized single blinded trial of C. officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer was conducted. Patients who had been operated on for breast cancer and who were to receive post-operative radiation therapy were randomly allocated to application of either Calendula ointment containing 20% of fresh Calendula aerial parts in petroleum jelly (126 patients) or trolamine (128 patients) on the irradiated fields after each session. The primary end point was the occurrence of acute dermatitis of grade 2 or higher. Secondary end points were the occurrence of pain, the quantity of the topical agent used and the patient satisfaction. The occurrence of acute dermatitis of grade 2 or higher was significantly lower (41% vs. 63%; P < 0.001) with the use of Calendula than with trolamine. Moreover, patients receiving Calendula had less frequent interruption of radiotherapy and significantly reduced radiation-induced pain.[80] Clinical examination of an ointment with C. officinalis extract was carried out in 34 patients with venous leg ulcer. A total of 21 patients with 33 venous ulcers were treated with ointment, applied twice a day for 3 weeks. Control group that consisted of 13 patients with 22 venous ulcers were treated with saline solution dressings, applied to ulcers for 3 weeks. In the experimental group, the total surface of all the ulcers at the beginning of the therapy was 67,544 mm2. After the 3rd week, the total surface of all the ulcers was 39,373 mm2 (a decrease of 41.71%). In seven patients, complete epithelialization was achieved. In the control group, the total surface of all ulcers at the beginning of the therapy was 69,722 mm2. After the 3rd week, the total surface of all ulcers was 58,743 mm2 (a decrease of 14.52%). In four patients, complete epithelialization was achieved. There was a statistically significant acceleration of wound healing in the experimental group (P < 0.05), suggesting the positive effects of the ointment with marigold extract on venous ulcer epithelialization.[81]

Toxicology

Although rare, skin contact with Calendula preparations may result in an allergic reaction to the herb. Sensitization to Calendula and allergic contact reactions have been reported.[82,83] There have also been incidents of anaphylactic shock after gargling with an infusion of Calendula.[84]

CONCLUSION

About 12-20 species of the genus Calendula have been reported in various floras. Among these, most of the ethnopharmacological reports are available on C. officinalis and C. arvensis. Further, only four species of Calendula have been partially investigated for their phytoconstituents. A close scrutiny of literature on Calendula reveals that three species have been investigated pharmacologically. Pharmacological studies reveal that C. officinalis exhibits antibacterial, antiviral, anti-inflammatory, anti-tumor and antioxidant properties; C. arvensis possesses antibacterial, anti-inflammatory, antimutagenic and hemolytic activities; and C. suffruticosa exhibits antimicrobial activity. C. officinalis has been included in number of herbal formulations, which are in clinical use for the treatment of various ailments like central nervous system disorders. Keeping in view the ethnopharmacology, phytochemical and pharmacological reports, low toxicity and frequency of use, C. officinalis seems to hold great potential for in depth investigation for various biological activities. Few preliminary pharmacological reports support medicinal potential of some Calendula species. These species need to be investigated systematically with a view to establish their varied pharmacological activities and mode of actions.

Footnotes

Source of Support: Financial assistance has been provided by UGC

Conflict of Interest: None declared

REFERENCES

  • 1.Baciu AD, Mihalte L, Sestras AF, Sestras RE. Variability of decorative traits, response to the Aphis fabae attack and RAPD diversity in different genotypes of Calendula. Not Bot Hort Agrobot Cluj. 2010;38:265–70. [Google Scholar]
  • 2.Naguib NY, Khalil MY, El Sherbeny SE. A comparative study on the productivity and chemical constituents of various sources and species of Calendula plants as affected by two foliar fertilizers. J Appl Sci Res. 2005;1:176–89. [Google Scholar]
  • 3.Ghorbani A. Studies on pharmaceutical ethnobotany in the region of Turkmen Sahra, north of Iran (Part 1): General results. J Ethnopharmacol. 2005;102:58–6. doi: 10.1016/j.jep.2005.05.035. [DOI] [PubMed] [Google Scholar]
  • 4.Tiwari S. Plants: A rich source of herbal medicine. J Nat Prod. 2008;1:27–33. [Google Scholar]
  • 5.Anonymous. Vol. 1. New Delhi: National Institute of Sciences Communication and Information Resources, Council of Scientific and Industrial Research; 2000. pp. 185–6. [Google Scholar]
  • 6.Dall’Acqua S, Cervellati R, Loi MC, Innocenti G. Evaluation of in vitro antioxidant properties of some traditional Sardinian medicinal plants: Investigation of the high antioxidant capacity of Rubus ulmifolius. Food Chem. 2008;106:745–9. [Google Scholar]
  • 7.Abbasi AM, Khan MA, Ahmad M, Zafar M, Jahan S, Sultana S. Ethnopharmacological application of medicinal plants to cure skin diseases and in folk cosmetics among the tribal communities of North-West Frontier Province, Pakistan. J Ethnopharmacol. 2010;128:322–35. doi: 10.1016/j.jep.2010.01.052. [DOI] [PubMed] [Google Scholar]
  • 8.Passalacqua NG, Guarrera PM, De Fine G. Contribution to the knowledge of the folk plant medicine in Calabria region (Southern Italy) Fitoterapia. 2007;78:52–68. doi: 10.1016/j.fitote.2006.07.005. [DOI] [PubMed] [Google Scholar]
  • 9.Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H. Medicinal flowers. III. Marigold. (1): Hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull (Tokyo) 2001;49:863–70. doi: 10.1248/cpb.49.863. [DOI] [PubMed] [Google Scholar]
  • 10.Blumenthal M, Goldberg A, Brinckmann J. Austin, TX, Boston: American Botanical Council, Integrative Medicine Communications; 2001. Herbal Medicine: Expanded Commission E Monographs; pp. 376–8. [Google Scholar]
  • 11.Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69:1692–6. doi: 10.1021/np068016b. [DOI] [PubMed] [Google Scholar]
  • 12.Rehecho S, Uriarte-Pueyo I, Calvo J, Vivas LA, Calvo MI. Ethnopharmacological survey of medicinal plants in Nor-Yauyos, a part of the Landscape Reserve Nor-Yauyos-Cochas, Peru. J Ethnopharmacol. 2011;133:75–8. doi: 10.1016/j.jep.2010.09.006. [DOI] [PubMed] [Google Scholar]
  • 13.Safdar W, Majeed H, Naveed I, Kayani WK, Ahmed H, Hussain S, et al. Pharmacognostical study of the medicinal plant Calendula officinalis L. (family Compositae) Int J Cell Mol Biol. 2010;1:108–16. [Google Scholar]
  • 14.Boericke W. New Delhi: Jain Publishers Pvt. Ltd; 1998. Pocket Manual of Homoeopathic Material Medica. B; pp. 156–83. [Google Scholar]
  • 15.Kasiram K, Sakharkar P, Patil A. Antifungal activity of Calendula officinalis. Indian J Pharm Sci. 2000;62:464–6. [Google Scholar]
  • 16.Cetkovic GS, Djilas SM, Canadanovic-Brunet JM, Tumbas VT. Antioxidant properties of marigold extracts. Food Res Int. 2004;37:643–50. [Google Scholar]
  • 17.Page L. Carmel Valley, California, United States of America: Healthy Healing Publications; 1998. Detoxification: All You Need to Know to Recharge, Renew and Rejuvenate Your Body, Mind and Spirit; pp. 191–2. [Google Scholar]
  • 18.Khare CP. New York, USA: Springer Science Business Media, LLC; 2007. Indian Medicinal Plants: An Illustrated Dictionary; pp. 111–2. [Google Scholar]
  • 19.Maryland: 2011. UMMC. Calendula. University of Maryland Medical Centre, Baltimore. Available from: http://www.umm.edu/altmed/articles/calendula-000228.htm . [Google Scholar]
  • 20.Wynn SG, Fougere B. Philadelphia, USA: Mosby Elsevier; 2007. Veterinary Herbal Medicine; pp. 501–3. [Google Scholar]
  • 21.Miliauskas G, Venskutonis PR, Van Beek TA. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem. 2004;85:231–7. [Google Scholar]
  • 22.Schneider C. Traumeel-an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011;4:225–34. doi: 10.2147/IJGM.S16709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med. 2001;155:796–9. doi: 10.1001/archpedi.155.7.796. [DOI] [PubMed] [Google Scholar]
  • 24.Sarrell EM, Cohen HA, Kahan E. Naturopathic treatment for ear pain in children. Pediatrics. 2003;111:e574–9. doi: 10.1542/peds.111.5.e574. [DOI] [PubMed] [Google Scholar]
  • 25.Ruiz de Clavijo E. The reproductive strategies of the heterocarpic annual Calendula arvensis (Asteraceae) Acta Oncol. 2005;28:119–26. [Google Scholar]
  • 26.Paolini J, Barboni T, Desjobert JM, Djabou N, Muselli A, Costa J. Chemical composition, intraspecies variation and seasonal variation in essential oils of Calendula arvensis L. Biochem Syst Ecol. 2010;38:865–74. [Google Scholar]
  • 27.Bisset NG, Wichtl M. 2nd ed. Stuttgart, Germany: Medpharm Scientific Publishers; 2001. Herbal Drugs and Phytopharmaceuticals; pp. 118–20. [Google Scholar]
  • 28.Mills SY. Harmondsworth, Middlesex: Penguin Books Ltd; 1992. The Essential Book of Herbal Medicine. [Google Scholar]
  • 29.Jackson BP, Snowdon DW. New Delhi: CBS Publishers and Distributors (P) Ltd; 1992. Atlas of Microscopy of Medicinal Plants: Culinary Herbs and Spices; p. 154. [Google Scholar]
  • 30.Vol. 2. Geneva: World Health Organization; 2002. WHO. WHO Monographs on Selected Medicinal Plants; pp. 35–44. [Google Scholar]
  • 31.Booth CO. Vol. 2. Delhi: Daya Books; 1999. Encyclopaedia of Garden Plants; pp. 202–3. [Google Scholar]
  • 32.Loudon J. London: W. Smith; 1811. The Ladies’ Flower-Garden of Ornamental Annuals; p. 206. [Google Scholar]
  • 33.Tutin TG. Vol. 4. Cambridge, United Kingdom: University Press; 1976. Flora Europaea: Plantaginaceae to Compositae (and Rubiaceae) pp. 206–7. [Google Scholar]
  • 34.Silwowski J, Dziewanowska K, Kasprzyk Z. Ursadiol: A new triterpene diol from Calendula officinalis flowers. Phytochemistry. 1973;12:157–60. [Google Scholar]
  • 35.Wilkomirski B, Kasprzyk Z. Free and ester bound triterpene alcohols and sterols in cellular subfractions of Calendula officinalis flowers. Phytochemistry. 1979;18:253–5. [Google Scholar]
  • 36.Marukami T, Kishi A, Yoshikawa M. Medicinal flowers. IV. Marigold. (2): Structures of new ionone and sesquiterpene glycosides from Egyptian Calendula officinalis. Chem Pharm Bull (Tokyo) 2001;49:974–8. doi: 10.1248/cpb.49.974. [DOI] [PubMed] [Google Scholar]
  • 37.Bakó E, Deli J, Tóth G. HPLC study on the carotenoid composition of Calendula products. J Biochem Biophys Methods. 2002;53:241–50. doi: 10.1016/s0165-022x(02)00112-4. [DOI] [PubMed] [Google Scholar]
  • 38.Cetkovic GS, Dilas SM, Brunet JM, Tumbas VT. Thin-layer chromatography analysis and scavenging activity of marigold (Calendula officinalis L) extracts. Acta Periodica Technologica. 2003;34:93–102. [Google Scholar]
  • 39.Gruenwald J. 2nd ed. Montvale, New Jersey, USA: Medical Economics Company; 2000. PDR for Heral Medicines; pp. 497–500. [Google Scholar]
  • 40.Okoh OO, Sadimenko AA, Afolayan AJ. The effects of age on the yield and composition of the essential oils of Calendula officinalis. J Appl Sci. 2007;7:3806–10. [Google Scholar]
  • 41.Janiszowska W, Michalski W, Kasprzyk Z. Polyprenyl quinones and [alpha]-tocopherol in Calendula officinalis. Phytochemistry. 1976;15:125–7. [Google Scholar]
  • 42.Ulchenko NT, Glushenkova AI, Mukhamedova KS. Lipids of Calendula officinalis. Chem Nat Compd. 1998;34:272–4. [Google Scholar]
  • 43.Anonymous. Vol. 3. New Delhi: Publications and Information Directorate, Council of Scientific and Industrial Research; 1992. The Wealth of India; pp. 55–8. [Google Scholar]
  • 44.Chemli R, Babadjamian A, Faure R, Boukef K, Balansard G, Vidal E. Arvensoside A and B, triterpenoid saponins from Calendula arvensis. Phytochemistry. 1987;26:1785–8. [Google Scholar]
  • 45.Kirmizibekmez H, Bassarello C, Piacente S, Pizza C, Calis I. Triterpene saponins from Calendula arvensis. Zeitschrift fur Naturforschung B. J Chem Sci. 2006;61:1170–3. [Google Scholar]
  • 46.Vidal-Ollivier E, Babadjamian A, Faure R, Chemli R, Boukef K, Balansard G. Two-dimensional NMR studies of triterpenoid glycosides. II. Hydrogen NMR assignment of arvensoside A and B, calenduloside C and D. Spectrosc Lett. 1989;22:579–89. [Google Scholar]
  • 47.Pizza C, de Tommasi N. Plants metabolites. A new sesquiterpene glycoside from Calendula arvensis. J Nat Prod. 1987;50:784–9. [Google Scholar]
  • 48.Pizza C, de Tommasi N. Sesquiterpene glycosides based on the alloaromaden-drane skeleton from Calendula arvensis. Phytochemistry. 1988;27:2205–8. [Google Scholar]
  • 49.Asolkar LV, Kakkar KK, Chakre OJ. Part-1. New Delhi: Council of Scientific and Industrial Research; 1992. Glossary of Indian Medicinal Plants with Active Principles; p. 153. [Google Scholar]
  • 50.Chisholm MJ, Hopkins CY. Calendic acid in seed oils of the genus Calendula. Can J Biochem. 1967;45:251–4. doi: 10.1139/o67-028. [DOI] [PubMed] [Google Scholar]
  • 51.Chemli R, Boukef K, Balansard G, Gayte-Sorbier A. Study of amino acids in Calendula arvensis eu arvensis Maire. Plantes Medicinales et Phytother. 1986;20:203–9. [Google Scholar]
  • 52.Suh JD. Method for preparaing highly pure lutein by extracting Calendula arvensis and saponification thereof with using harmless organic solvent. Korean Kongkae Taeho Kongbo. 2006:248–54. [Google Scholar]
  • 53.Lavagna SM, Secci D, Chimenti P, Bonsignore L, Ottaviani A, Bizzarri B. Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco. 2001;56:451–3. doi: 10.1016/s0014-827x(01)01060-6. [DOI] [PubMed] [Google Scholar]
  • 54.Mamedova LA, Abasova RL, Aslanov SM, Mamedova ME. Fatty acid composition of the neutral lipids of Calendula persica. Chem Nat Compd. 1995;31:764–5. [Google Scholar]
  • 55.Chisholm M, Hopkins C. Kamlolenic acid and other conjugated fatty acids in certain seed oils. J Am Oil Chem Soc. 1966;43:390–2. doi: 10.1007/BF02915346. [DOI] [PubMed] [Google Scholar]
  • 56.Dumenil G, Chemli R, Balansard C, Guiraud H, Lallemand M. Evaluation of antibacterial properties of marigold flowers (Calendula officinalis L.) and mother homeopathic tinctures of C. officinalis L. and C. arvensis L. (author's transl) Ann Pharm Fr. 1980;38:493–9. [PubMed] [Google Scholar]
  • 57.De Tommasi N, Pizza C, Conti C, Orsi N, Stein ML. Structure and in vitro antiviral activity of sesquiterpene glycosides from Calendula arvensis. J Nat Prod. 1990;53:830–5. doi: 10.1021/np50070a009. [DOI] [PubMed] [Google Scholar]
  • 58.Chemli R, Toumi A, Oueslati S, Zouaghi H, Boukef K, Balansard G. Calendula arvensis L. Impact of saponins on toxicity, hemolytic effect, and anti-inflammatory activity. J Pharm Belg. 1990;45:12–6. [PubMed] [Google Scholar]
  • 59.Elias R, De Méo M, Vidal-Ollivier E, Laget M, Balansard G, Dumenil G. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L. Mutagenesis. 1990;5:327–31. doi: 10.1093/mutage/5.4.327. [DOI] [PubMed] [Google Scholar]
  • 60.Amirghofran Z, Azadbakht M, Karimi MH. Evaluation of the immunomodulatory effects of five herbal plants. J Ethnopharmacol. 2000;72:167–72. doi: 10.1016/s0378-8741(00)00234-8. [DOI] [PubMed] [Google Scholar]
  • 61.Varljen J, Liptak A, Wagner H. Structural analysis of a rhamno-arabinogalactan and arabinogalactans with immuno-stimulating activity from Calendula officinalis. Phytochemistry. 1989;28:2379–83. [Google Scholar]
  • 62.Popovic M, Kourinovic B, Mimica-Dukic N, Vojinovic-Miloradav M, Cupic V. Combined effects of plant extracts and xenobiotics on liposomal lipid peroxidation. Part I. Marigold extract-ciprofloxacin/pyralene. Oxid Commun. 1999;22:487–94. [Google Scholar]
  • 63.Popovic M, Kourinovic B, Mimica-Dukic N, Vojinovic-Miloradav M, Djordjevic A. Combined effects of plant extracts and xenobiotics on liposomal lipid peroxidation. Part II. Marigold extract-CCl4/fullerenol. Oxid Commun. 2000;23:178–86. [Google Scholar]
  • 64.Bezákova L, Masterová I, Paulíková I, Psenák M. Inhibitory activity of isorhamnetin glycosides from Calendula officinalis L. on the activity of lipoxygenase. Pharmazie. 1996;51:126–7. [PubMed] [Google Scholar]
  • 65.Schmidgall J, Schnetz E, Hensel A. Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Planta Med. 2000;66:48–53. doi: 10.1055/s-2000-11118. [DOI] [PubMed] [Google Scholar]
  • 66.Boucaud-Maitre Y, Algernon O, Raynaud J. Cytotoxic and antitumoral activity of Calendula officinalis extracts. Pharmazie. 1988;43:220–1. [PubMed] [Google Scholar]
  • 67.Yasukawa K, Akihisa T, Oinuma H, Kaminaga T, Kanno H, Kasahara Y, et al. Inhibitory effect of taraxastane-type triterpenes on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 1996;53:341–4. doi: 10.1159/000227584. [DOI] [PubMed] [Google Scholar]
  • 68.Samochowiec L. Pharmakologische untersuchungen der saponosiden von Aralia mandshurica rupr. et Maxim. und Calendula officinalis L. Herba Pol. 1983;29:151–5. [Google Scholar]
  • 69.Wojcicki J, Samochowiec L. Comparative evaluation of the effect of Aralia mandshurica Rupr. et Maxim and Calendula officinalis L. saponosides on lipid level in blood serum and liver homogenates. Herba Pol. 1980;26:233–7. [Google Scholar]
  • 70.Bojadjiev C. On the sedative and hypotensive effect of preparations from the plant Calendula officinalis. Nauchni Tr Vissh Med Inst Sofiia. 1964;43:15–20. [PubMed] [Google Scholar]
  • 71.Kalvatchev Z, Walder R, Garzaro D. Anti-HIV activity of extracts from Calendula officinalis flowers. Biomed Pharmacother. 1997;51:176–80. doi: 10.1016/s0753-3322(97)85587-4. [DOI] [PubMed] [Google Scholar]
  • 72.Casley-Smith JR, Casley-Smith JR. The effect of “Unguentum lymphaticum” on acute experimental lymphedema and other high-protein edemas. Lymphology. 1983;16:150–6. [PubMed] [Google Scholar]
  • 73.Janssen AM, Chin NL, Scheffer JJ, Baerheim Svendsen A. Screening for antimicrobial activity of some essential oils by the agar overlay technique. Pharm Weekbl Sci. 1986;8:289–92. doi: 10.1007/BF02280052. [DOI] [PubMed] [Google Scholar]
  • 74.Kubas J. Investigations on known or potential antitumoural plants by means of microbiological tests. Part III. Activity of some cultivated plant species in Neurospora crassa test. Acta Biol Cracov Ser Bot. 1972;15:87–100. [Google Scholar]
  • 75.Ríos JL, Recio MC, Villar A. Antimicrobial activity of selected plants employed in the Spanish Mediterranean area. J Ethnopharmacol. 1987;21:139–52. doi: 10.1016/0378-8741(87)90124-3. [DOI] [PubMed] [Google Scholar]
  • 76.Setty BS, Kamboj VP, Khanna NM. Screening of Indian plants for biological activity: Part VII – Spermicidal activity of Indian plants. Indian J Exp Biol. 1977;15:231–2. [PubMed] [Google Scholar]
  • 77.Radioza SA, Iurchak LD. Antimicrobial activity of Calendula L. plants. Mikrobiol Z. 2007;69:21–5. [PubMed] [Google Scholar]
  • 78.Lievre M, Marichy J, Baux S, Foyatier JL, Perrot J, Boissel JP. Controlled study of three ointments for the local management of 2nd and 3rd degree burns. Clin Trials Meta-Anal. 1992;29:9–12. [Google Scholar]
  • 79.Baranov A. Calendula: How effective is it on burns and scalds. Deutsche Apotheker Zeitung. 1999;139:61–6. [Google Scholar]
  • 80.Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447–53. doi: 10.1200/JCO.2004.07.063. [DOI] [PubMed] [Google Scholar]
  • 81.Duran V, Matic M, Jovanovć M, Mimica N, Gajinov Z, Poljacki M, et al. Results of the clinical examination of an ointment with marigold (Calendula officinalis) extract in the treatment of venous leg ulcers. Int J Tissue React. 2005;27:101–6. [PubMed] [Google Scholar]
  • 82.Neto J, Fracasso J, Camargo Neves C. Treatment of varicose ulcer and skin lesions with Calendula officinalis L. or Stryphnodendron barbadetiman (Vellozo) Martius. Rev Bras Cienc Farm. 1996;17:181–6. [Google Scholar]
  • 83.Hausen BM, Oestmann G. The incidence of occupationally-induced allergic skin diseases in a large flower market. Derm Beruf Umwelt. 1988;36:117–24. [PubMed] [Google Scholar]
  • 84.Gol’dman II. Anaphylactic shock after gargling with an infusion of Calendula. Klin Med (Mosk) 1974;52:142–3. [PubMed] [Google Scholar]

Articles from Pharmacognosy Reviews are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES